Incorporated in 1911, International Business Machines, or IBM, is one of the oldest technology companies in the world... Show more
International Business Machines shares closed around $232.14 in the most recent session, a modest gain of roughly 1% over the trailing 30 days. That stability masks a volatile stretch: the stock remains about 25% below its June 2026 record above $329, yet roughly 16% above its July 2026 intraday low near $199. The dividend stands at $1.69 per share per quarter, implying a yield near 2.9%, and the company continues to be widely followed as a diversified enterprise-technology bellwether. Investor attention now centers on third-quarter results scheduled for October 21.
IBM is a global enterprise-technology company spanning hybrid cloud, artificial intelligence, software, consulting, and infrastructure. Its software portfolio—anchored by Red Hat, automation, and data and AI offerings—now generates roughly 45% of total revenue and an even larger share of profit, making it the engine of the growth story. The company also operates a consulting business, a mainframe (IBM Z) franchise that underpins mission-critical transaction processing for banks and other large institutions, and an active quantum-computing program. IBM's competitive strengths include deep enterprise relationships, a large base of recurring subscription revenue, and a decades-long record of dividend increases.
The defining event of the past quarter was IBM's July 14 preliminary results warning. CEO Arvind Krishna disclosed that numerous large deals failed to close as expected in late June, as customers redirected spending toward servers, storage, and memory ahead of anticipated price increases, while industry-wide cybersecurity concerns also delayed decisions. The announcement erased about 25% of the stock's value in one session.
Final second-quarter results, reported July 22, showed revenue of $17.16 billion, up 1% year over year. Software revenue rose 5% to $7.76 billion, consulting was roughly flat, and infrastructure declined 7%, with IBM Z mainframe revenue down 42%. Management lowered its full-year constant-currency revenue growth outlook to 4%–5%. Nearly all of the software segment's growth was attributed to the roughly $11 billion acquisition of data-streaming provider Confluent (CFLT), which closed in March, while organic software was essentially flat.
In October, sentiment showed signs of stabilizing. Bank of America reiterated a Buy rating with a $280 target, J.P. Morgan maintained a $250 target, and Morgan Stanley raised its target to $238 from $190 while keeping an Equal-Weight stance. IBM also advanced to Stage C of DARPA's Quantum Benchmarking Initiative in early October, and strong results from consulting peer Accenture (ACN) briefly lifted sentiment around enterprise IT spending.
Investors tracking IBM and other actively traded names can also monitor algorithmic strategies through Tickeron's Trending AI Robots page. Tickeron offers hundreds of AI trading bots across thousands of tickers, but only the top-performing and most relevant bots are highlighted in this curated section. The featured robots vary by strategy, holding timeframe, and performance metrics, giving traders a view into which automated approaches are currently resonating in the market. Those interested in exploring data-driven trading signals can browse the section to see how different AI models are positioned.
The immediate catalyst is IBM's third-quarter report on October 21, where the key metric will be whether organic software growth—not just acquisition-driven gains—has reaccelerated and whether the large deals that slipped in Q2 have closed. Management's guidance for 6%–8% full-year software growth depends on a stronger second half. Beyond earnings, investors are watching the mainframe cycle, consulting demand, competitive pressures from AI-native vendors, and the pace of free-cash-flow generation, which IBM expects to increase by about $1 billion in 2026. Quantum computing remains a longer-dated option rather than a near-term revenue driver. None of this constitutes a recommendation, and outcomes will depend on execution and broader enterprise IT spending trends.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day moving average for IBM crossed bullishly above the 50-day moving average on October 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 79%.
The Momentum Indicator moved above the 0 level on October 09, 2026. You may want to consider a long position or call options on IBM as a result. In 50 of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 62%.
The Moving Average Convergence Divergence (MACD) for IBM just turned positive on October 09, 2026. Looking at past instances where IBM's MACD turned positive, the stock continued to rise in 24 of 37 cases over the following month. The odds of a continued upward trend are 65%.
IBM moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +3.21% 3-day Advance, the price is estimated to grow further. Considering data from situations where IBM advanced for three days, in 248 of 375 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IBM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 54%.
IBM broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for IBM entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 29 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 39 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. IBM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 77 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.050) is normal, around the industry mean (2.620). P/E Ratio (22.497) is within average values for comparable stocks, (17.865). Projected Growth (PEG Ratio) (2.087) is also within normal values, averaging (2.284). Dividend Yield (0.026) settles around the average of (0.172) among similar stocks. P/S Ratio (3.271) is also within normal values, averaging (139.965).
The Tickeron PE Growth Rating for this company is 84 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of various computer products through the use of advanced information technology
Industry InformationTechnologyServices